|
| |
| |
Pharmaceutical Strategy Series
presents....
Licensing &
Partnering Congress
November 18-19, 2004
Cambridge,
MA |
REGISTER BY OCTOBER 15th & SAVE UP TO $200!
|
|
|
|
|
Download
Brochure
Register Now!
Models to Evaluate the
ROI of New
Technologies
Can Licensing Strategies
Alter the High
Rate
of Failure for New Chemical
Entities?
Symbiosis of Large Pharma
and Biotech:
Getting the Interactions Right
Through
to Due
Diligence
Complementing Internal
R&D with External
Innovation
Strategies to Protect
Intellectual Property
During Negotiations |
 |
|
2004 Emerging Company
Partnering Forum
November 18,
2004 |
4 3DM, Inc.
4 Dynogen
Pharmaceuticals, Inc.
4 Faust Pharmaceuticals
4 Genodive
4 Gloucester Pharmaceuticals,
Inc. |
4 Innovadigm
Oncology
4 Molecular
Therapeutics, Inc
4 Quintessence Biosciences, Inc.
4 Reify Corporation
4 TransTech Pharma
Inc |
Expert
Critique Panel
- Gregory Bell, Ph.D.,
M.B.A., Vice President, Pharmaceutical Practice,
Charles River Associates
-
Robert Gould, Vice President, Licensing & External
Research,
Merck Research Labs,
- Lisa Gray, Managing Partner, Phoenix IP
Ventures (former Director at GSK
Ventures)
- Michael Lytton, J.D.,
M.Sc., General Partner, Oxford Bioscience Partners
| |
Download Brochure
Register Now!
Or for more
information, visit: www.healthtech.com/2004/lic
|
|
This email has
been circulated by BioPortfolio Ltd on behalf of Cambridge Healthtech
Institute Inc. As a registered user of the
BioPortfolio web sites, you were selected to receive this message in the genuine belief that it would be of interest to you.
Subscriber
information:
To
unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com
WITH NO SUBJECT. The system will automatically remove your email address
from the list based on your email address. If your email has changed
please email peter.barfoot@bioportfolio.com
with a list of your email address and we will manually unsubscribe for you.
Thank you for your understanding.
To subscribe
for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com
Disclaimer:
BioPortfolio Limited
and its agents used their best efforts in collecting and
preparing the information published herein. However,
BioPortfolio does not assume, and hereby disclaims, any and
all liability for any loss or damage caused by errors, whether
such errors resulted from negligence, accident, or other
causes. All rights reserved. ©2004 BioPortfolio Limited |
 |
|
BioPortfolio is the
essential web resource for scientists, executives, investors, the public
and the patient with an interest in who, what, where, when
and why biotechnology will impact on our lives. We have created
proprietary databases and search engines that will support your business
and private interests in the most exiting technology of the 21st Century. BioPortfolio provides
14
Channels: www.bioportfolio.com/
|
| |
|
